Ropinirole XL (formerly CR)
Sponsors
GlaxoSmithKline
Conditions
Parkinson DiseaseParkinson's Disease
Phase 3
An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease
CompletedNCT00632736
Start: 2004-02-29End: 2010-03-31Updated: 2017-03-23
Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164
CompletedNCT00650104
Start: 2002-05-31End: 2009-03-31Updated: 2013-05-06